Mirati Therapeutics, Inc.
Bristol Myers Squibb is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases. The company is committed to transforming lives through science, with a focus on patient-centric solutions, scientific innovation, and responsible business practices. It operates worldwide, with a strong emphasis on research, diversity, and community support.
Industries
Nr. of Employees
large (251-1000)
Mirati Therapeutics, Inc.
Products
Therapeutic medicines portfolio across major disease areas
A portfolio of approved medicines and development-stage therapeutics for oncology, cardiovascular disease, immunological disorders and hematology.
Therapeutic medicines portfolio across major disease areas
A portfolio of approved medicines and development-stage therapeutics for oncology, cardiovascular disease, immunological disorders and hematology.
Services
Clinical trial operations and trial-matching services
Design and operational support for clinical studies and a public trial search/matching service for investigators and participants.
Medical information portals for healthcare professionals
Online medical information services providing product and disease information to HCPs.
Patient assistance and access programs
Financial assistance and support services to help eligible patients access prescribed therapies.
Medical education grants and sponsored training
Funding programs and scholarships to support healthcare professional education and conference participation.
Business development and partnership facilitation
External partnering, licensing and collaboration activities to extend therapeutic pipelines and capabilities.
Clinical trial operations and trial-matching services
Design and operational support for clinical studies and a public trial search/matching service for investigators and participants.
Medical information portals for healthcare professionals
Online medical information services providing product and disease information to HCPs.
Patient assistance and access programs
Financial assistance and support services to help eligible patients access prescribed therapies.
Medical education grants and sponsored training
Funding programs and scholarships to support healthcare professional education and conference participation.
Business development and partnership facilitation
External partnering, licensing and collaboration activities to extend therapeutic pipelines and capabilities.
Expertise Areas
- Clinical trial management
- Immuno-oncology
- Cell therapy / CAR-T
- Oncology research
Key Technologies
- Immuno-oncology platforms
- CAR-T and cell therapy technologies
- Radiopharmaceutical therapies
- Digital health applications (patient-facing)